Methylprednisolone suleptanate
Alternative Names: Medrosol; PNU 67590A; Promedrol; U 67590ALatest Information Update: 05 May 2004
At a glance
- Originator Pfizer
- Class Anti-inflammatories; Antiasthmatics; Corticosteroids
- Mechanism of Action Immunosuppressants; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Lupus nephritis; Nephrotic syndrome; Spinal cord injuries
Most Recent Events
- 05 May 2004 No development reported - Phase-II for Lupus nephritis (Injection)
- 05 May 2004 No development reported - Phase-III for Asthma in Japan (Injection)
- 05 May 2004 No development reported - Preclinical for Spinal cord injuries (Injection)